Tag Archives: NIH

Statement on Harvard’s Decision to Close the New England Primate Research Center

Speaking of Research is saddened to learn about Harvard’s decision to wind down operations at the New England Primate Research Center (NEPRC) within the next two years.

Over the years the Primate Center has contributed important discoveries in many fields, including AIDS, Parkinson’s disease, primate retroviruses, addiction, cardiology and stem cells.

The University cited difficult financial times and shifting long-term strategic plans as the reason for the closing.  Meanwhile animal right activists groups fought among themselves to take credit for Harvard’s decision.

Perhaps a combination of both, the planned closure is a reflection of decreasing Federal support for medical research and a growing anti-scientific movement in the United States and elsewhere.

In Harvard’s decision one can find many lessons for the scientific community, NIH and the public at large, which are likely to be the subject of debate and discussion in the near future. The wider research community will need work together with faculty and staff at NEPRC to ensure that Harvard Medical school keeps to its commitment to provide full support to them during this transition, so that vital research programs and gifted personnel are not lost to science.

For now Speaking of Research join others in expressing our surprise and disappointment at these developments, and offer our support for the scientists, staff and others affected by these events.

Speaking of Research

A Public Conversation on Animal Ethics: The good, the bad, and the ugly

The UW-Madison recently hosted a conversation on the ethics of animal research between Rick Marolt, an opponent of animal research, and Robert Streiffer, a bioethicist at the university and member of the Institutional Animal Care and Use Committee (IACUC).

Here are some of my thoughts on this interesting exchange.

The good: Above all, it is good to see a display of open academic dialogue on a controversial topic.  We have tried such a conversation at UCLA in the past with mixed results. This meeting was described as a “conversation” rather than a “debate”.  Such dialogue is a good first step that allow participants to express their positions on the ethics of animal research. In this regard, I think such exercises are a net good and a sign of progress.

The curious: It is perplexing that the conversation centered on the use of a “utilitarian framework” to justify the use of animals in medical research. Why? Because both participants made it clear they are not utilitarians. Instead, they both (wrongly) declared that scientists are, or assumed the only possible justification for their work must be a utilitarian one. The result was that Prof. Streiffer, on more than one occasion, uttered a sentence beginning with “It is because they [scientists] think that..,” while not being clear on what his own ethical framework as Chair of the IACUC has been. Of course, if the participants were seeking an utilitarian justification for animal research they could have invited Peter Singer.

My sense is that scientists hold a wide range of more nuanced views that they certainly include the consideration of benefits, but are not defined by the utilitarian position. Rather than letting someone speak for us, scientists should let our voices be heard, both to explain the science and ethics of the work.

Mind the gap: The discussion centered exclusively on the upper limits of animal research.  In other words, what kind of experiments would one find to be unjustifiable? Marolt and Streiffer probed this issue using a maternal deprivation protocol at UW as a test case. I think this is a good question to ask. At the same time, if one truly want to explore the size of the gap that exists between our respective positions, we must also ask what kind of experiments the critics of animal research would find acceptable and why. This point was altogether ignored and Mr. Marolt offered no examples. Given the ethical principles he cited (see below), I’d guess his answer would be “none at all”. Understanding the gap between opposing views is critical to identify areas of common ground, or lead us to conclude that there cannot be any.

The bad: To a scientist, perhaps the most shocking passage of the exchange came when both participants agreed that “knowledge is not a significant benefit.” Such an insult to reason is deeply troubling because it shows how little the participants know about the scientific process. They also seem not to appreciate the value of negative results (disproving a hypothesis) in scientific inquiry.

Presumably, neither Marolt or Streiffer see much value in proving abstract mathematical theorems, engaging in space exploration, trying to manipulate single atoms, proving the existence of the Higgs boson, or placing a telescope in space to peek into the boundaries of the universe. They are apparently oblivious, for example, as to the origins of the medical imaging technologies such as X-rays, PET, ultrasound, and MRI. (Hint: basic knowledge.)

The inconsistent: Prof. Streiffer explained how he arrived at the conclusion that a protocol under discussion was unjustified based on his cost/benefit analysis. However, he previously stated that he didn’t fully understand how is that the scientists would be analyzing the data to determine the molecular pathways involved in anxiety. How was he able to assess the potential benefits of the work without such understanding?  It is not clear.

The double standard: Mr. Marolt tried to explain his opposition to animal research based on his “moral intuitions.”  However, he is unwilling to accept the use of “moral intuitions” argument from others, demanding instead solid ethical reasoning. He should apply the same high standards of ethical reasoning he demands from scientists to himself.

The “moral intuitions”: So what are Marolt’s moral intuitions? He said that in his view “life matters” and that we should not deprive anyone from the opportunity to life.

Does he mean this in absolute terms? Is he anti-abortion? Does he believe the use of violence to end slavery or free concentration camps was unjustified?  Does he see any situation at all in which taking a life may be justified?

He said that “suffering matters,” and that he feels the suffering of the monkeys in labs while lying in bed at night. I know that those working with animals also feel in such a way, but they also feel for the mothers that fight breast cancer, the children with leukemia, the elderly with Alzheimer’s or Parkinson’s. Their suffering matters to them too.

We all protect our children against enormous suffering by vaccinations that were developed through the use of animals in research.  We recognize the moral dilemma of the work. Not having children of his own Marolt did not have such experience, but he found no shortage of words when it came to offer suggestions as to how others must educate their children on moral issues.

Marolt said that species membership is not morally relevant because “he does not feel that.” Once again, if we accept this justification, those who support the work could simply respond that “we feel otherwise.” But it is unlikely that he would accept such explanation. What we would like to know is why he thinks we owe the same exact level of moral consideration to a mouse as to a human. We are asking for a reason, not a feeling.  Here are some reasons why cognitive abilities matter, as they impact the level of suffering of different organisms.

Finally, Marolt asserted that if faced with a situation where he had to choose between two living beings, a human and an animal, he would save the life of a human. But he explained he would not be able to rationalize his choice.

One can only infer that if Marolt had a better understanding of the science he would  approve of animal research.  Indeed, scientists feel we are in a sort of burning house scenario. Most of us feel that human lives will be lost if we stop the work and that, at present, there are no viable alternatives. We accept we have to live with the uncertainty of the benefits that any one experiment could yield. At the same time we are certain of the benefits of the work as a whole, as proven by medical history.  We are convinced that stopping scientific work with animals means that many areas of medical research would come to a full stop, with tremendous harm done to humans and animals alike.

Rick Marolt, and other animal rights activists like him, have to justify their inaction and their demand to have this type of work abolished. Not with feelings and intuitions, but with moral reasoning. They have not yet produced a compelling argument, and their absolutist, moral intuitions are wrong.

A Closer Look at How Animal Research Progresses from Idea to Study

Unfortunately, the “how” and “why” of the research process is of much less interest, and receives far less attention, than the “what did they find?!” part of research. The latter is what you’ll see—if we’re lucky from the science outreach perspective— on television, in the science and popular media, Facebook, Twitter, and conversations world-wide. Meanwhile, the former will be relegated to websites of federal agencies, scientific societies, and animal research advocacy groups and are read less widely.  In fact, it is entirely possible that a great many bets could be won by wagering that the public generally doesn’t care to read up on regulation or processes governing the research behind the cool discoveries that make news.

In the case of animal-based research (and some other controversial fields), the “how” and “why” do sometimes generate some public interest because they are keystones in considering questions about its ethical basis and evaluation.  Public understanding and discussion of the process by which science moves forward is important. It provides appropriate context for fact-based dialogue about the ethical evaluation, decision-making, and regulation that govern a wide range of science conducted within our democratic system. Thus, many scientists and advocates not only welcome public interest in the conduct of science, but also actively promote thoughtful, engaged, and informed collaboration on efforts for improving research practices.

Why? One reason is that the ultimate benefactor from scientific studies is the public and, within a democratic society, it is for all of us to decide whether the benefits of those studies outweigh their costs.  Another reason is that scientists are generally sensitive and responsive to societal views, but feel an obligation to ensuring that these views are informed by facts as well as emotional appeals.  This is an issue that is not at all unique to animal research. It also appears in discussions of other topics that can elicit controversy, including for example: evolution, climate change, use of embryonic stem cells, and vaccines.

For animal research, the challenges inherent in serious evaluation of its costs and benefits are not trivial. Nor is it amendable to flashy, sensationalized, and emotion-evoking campaigns.  Simplistic approaches to this issue are not useful and do a disservice to all of us.

From our perspective, it is both disappointing and frustrating to find that understanding of the process by which science moves from idea, to the conducting of the study, to the dissemination of the findings, to the evaluation of those findings receives far less attention than would be needed in order to rationally discuss the research.  Why?  Because the reality of how science is actually conducted is centrally relevant to conversations about science.  And while this is an obvious statement, it is also clear from many portrayals of science by opposing groups that the basics of scientific process and conduct are often missed in the discussion.

In the case of laboratory animal research, the starting point of many opponents is an absolutist position in which the conditions for animals, the ultimate outcome of the research, and its benefits, are irrelevant. They are irrelevant because the starting assumption is that the use of animals is morally unacceptable. For those who hold this view, there is no benefit that would justify the animal use.  There are others who hold a less absolute view and, like us, believe that the use of animals in research begins with moral and ethical consideration that requires thoughtful, fact-based weighing of both relative harm and benefit.  One major part of this evaluation is identifying whether alternatives exist to meet the same goal.  Another is identifying as closely as possible what harm may be incurred, the probability and extent of benefits. Each of these considerations is integral to regulation of animal research in the U.S. and elsewhere. They are also considerations that are so integral to the scientific process that they operate far beyond those stages typically identified as the “checks” for ethical and humane conduct of animal research (e.g., IACUC review, federal oversight).

long haul slide

How scientific research moves from idea stage, to conducting a study, to success or failure, to critical review, to dissemination and use of findings is a process that can appear somewhat opaque to public view.  The pieces of information required to construct the general pathways are publicly available.  Putting them together, however, is not necessarily straightforward for those without immediate interest, expertise, or engagement.  So while the information is neither hidden nor made secret, it is of the type that can be easily misunderstood or misrepresented.

Should this gap in basic understanding and perspectives on how scientists’ ideas move from thinking to reality concern us?  The answer is yes.  Among other reasons, the gap serves as an impediment to an informed evaluation of science.  It also weighs heavily against productive dialogue about core issues of public interest.

How does an animal research project move from scientist’s idea to finished study?

In general, the process looks like this:  Scientists generate ideas that are based in careful study of what is known, what is not known, what methods already exist, what facts we have.  They next critically evaluate and review relevant previous literature and data–  often soliciting others’ expert knowledge–  to determine whether the idea is novel (has not already been tested),  of potential importance or significance, and feasible.

Thus, while some may have the impression that scientists roll out of bed in the morning, or have an aha-moment- then  move straight to the lab to conduct whatever study occurred to them via dream – this is not the way it typically works.

As illustrated, deciding on whether an idea is worth pursuing or not is driven by many factors. If the resulting data would have little potential benefit, few scientists are likely to pursue it. Why?  Because scientists have a lot of ideas and it makes no sense to expend energy on one that won’t be useful in terms of providing significant new knowledge or understanding.  It is also true that such ideas are unlikely to compete successfully in the different arenas of expert scientific review, including review for funding, publication, and citation.

research process

If a scientist judges his/her idea worth pursuing, the next step is likely to decide whether the study is feasible or practical. What does this mean?  In short, this is a question that revolves around ethical, economic, and practical issues.  On the ethical side, for animal research the scientist will consider animal welfare and treatment, any potential for harm.  Next, on the financial and practical sides, the scientist will consider how much the study will cost and whether the necessary work can even be done. During this initial stage the scientist will also critically evaluate whether the existing literature and facts provide adequate and strong platforms for the proposed study, or whether more basic and background data are needed to guide decisions before moving forward.

For that fraction of studies that survive the scientist’s own critical examination—and likely that of his/her collaborative group and colleagues—the scientist may decide to pursue the work. If so, for animal research the next step will be to write a proposal to the Institutional Animal Care and Use Committee (IACUC) in order to conduct a study.  In the U.S., IACUSs are among the main venues for thorough review of animal studies.  We have written previously about IACUCs and there is more information here.

In brief, the IACUC is comprised of individuals with veterinary and scientific expertise, as well as a public representative.  Animal studies do not proceed until the IACUC has reviewed and approved a proposal.  What do these protocols contain?  You can see some here, this site contains links to protocol forms from a range of institutions.  Although institutions vary in the format of applications, among other things, they include: information about what the study is designed to test, why it should be conducted, the literature review and strategies used to ensure that it is not unnecessarily duplicative, that alternatives do not exist, the number of animals proposed and justification for both the number and the species,  detailed description of all procedures,  and other details about the animals’ care and treatment.  In other words, the full range of information that the review committee will need in order to evaluate whether the study meets standards.

Is the IACUC process perfect in evaluating study protocols? No.  It is, however, the current system mandated by federal law and it is one that generally functions well to protect animal welfare.  It is also an evolving system, with scientists, veterinarians, federal agencies, science and animal welfare advocates engaged in its ongoing evaluation and improvement. Some of the criticisms of the existing system, however, neglect consideration of the larger context, the process by which research unfolds. For example, critics point to the fact that IACUCs approve the majority of studies put before them as evidence that “almost anything” a scientist could dream up receives approval.  In reality, IACUCs only review proposals that scientists write and submit. This means that the IACUC only sees study proposals that have already received some critical evaluation and that likely already fall within the constraints of current guidelines, practices, and norms.  Scientists, like others involved in animal research, take part in training and education about the range of issues related to animal welfare, humane treatment, and regulatory requirements.  As a result, they are generally not likely to write protocols that diverge from acceptable practices.

Following IACUC approval, the scientist may then begin conducting the study. It is often the case however, that IACUC approval is not the final step between idea and study.  Instead, for a new project, the scientist must also write a proposal to a funding agency in order to secure financial support for the research. In many cases in academic research, funding for these studies comes from federal agencies such as the National Institutes of Health or the National Science Foundation.  Competition for these funds is high and the majority of applications are not successful.  Those proposals that are funded have undergone rigorous review by a panel of scientists whose expertise is within the area of the proposal.  The criteria for review vary by agencies, but include very close examination of the significance of the research question, evaluation of its potential for success, scrutiny of the methods, expertise of the investigator, and quality of the facilities in which the research will be conducted.  The appropriateness of the animals chosen for study, their number, and their treatment are also subject to critical evaluation and discussion.  In sum, beyond IACUC review, many animal studies—including all of those funded by NIH, NSF, and other agencies— undergo another level of external expert scientific review.

Take-home message?  The evaluative process between a scientific idea, the conduct of a study, the results, and their evaluation, use, and further discovery is one with many steps and significant consideration.  The potential harm and benefit of each study receives review at each stage as well, both within and outside.

Research aimed at addressing basic, translational, or clinical questions relevant to advancing our scientific understanding and medical progress for humans and other animals is ultimately all aimed at questions with significance to many.  At the same time, it is also absolutely true that the benefits of research are not always directly or immediately apparent.  We simply do not know the answers before we conduct the work.  Furthermore, we can be confident—drawing from real conclusions from the history of science – that important, meaningful, generative breakthroughs are not entirely predictable.  As a result, it is no easy task to construct a metric by which to evaluate the potential benefit of research and to weigh that against any harm incurred during its conduct.

Considered carefully, the history of animal research and animal welfare are quite clear with respect to how the accomplishments of research and consideration of mutual interests in animal welfare provide the basis for progress in ethical and humanely-conducted animal research.   Public interests are served by dialogue based in fact and in clear accurate articulation of ethical frameworks from which animal research is considered.  Understanding the multiple levels at which research projects are evaluated from scientific and ethical perspectives is an integral starting point for this discussion.  Science doesn’t occur through simple processes or via a single stage of evaluation; nor should public dialogue about this complex issue.

Allyson J. Bennett

The Golden Goose Awards

Politicians sometimes deride research based on the what they perceive as being “silly” titles of federal funded grants.  If they spot a title that deals with “games”, for example, they may assume it deals with some sort of amusement of little value to society, instead of a deep, powerful branch of mathematics that describes the behavior of competing rational agents with much relevance to voting, economics, cooperation, and so on.  Animal rights activists also enjoy the hobby.  The latest example is IDA’s list of “ridiculous research” ,whose claims were sadly repeated by far too many news journalists who were clearly too lazy check if they were accurate.  There were some honorable exceptions, notably an excellent editorial entitled “When the facts ruin a good spin” in the Times Union, which discusses a project on the role of music as a conditioning stimulus for drug use ends with a statement with which we heartily agree:

What’s “ridiculous,” to borrow the press release’s language, is that we fall for it, over and over, egged on by politicians eager to score easy points. And what’s “wasteful” is the time and energy that could be so much better spent on something other than a cheap shot.”

Back in 1976 the House Committee on Appropriations asked the National Science Foundation “Why does the Foundation persist in supporting research whose results have no apparent value to the American people?“  The NSF responded in part that:

Basic research seeks an understanding  of the laws of nature  without  initial  regard  for specific  utilitarian  value. Ultimately, however, it  is of the  most important  practical significance, because in a broad sense it is the foundation upon  which rests  all technological development.  Applied research builds on the results of basic research, seeking detailed  information  about  a specific situation  whose general laws have  been  discovered by  basic  research.  The  final step  toward  utilization  of research-development is  the systematic  application  of knowledge to  the  design  of  end products. [...]

As we  increase  our  knowledge  of nature  and  mankind,  in order  to adjust  nature  to our survival, safety,  comfort and convenience, we must  depend  upon  scientific research  to clarify the  relationships  of many, many things.  Thus,  we study  atoms,  even  though  they  will never  be seen  by an  unaided  human  eye.  We study  stars  too  faint  to  be  seen without  a  telescope  and  with  wavelengths  which  can  only be  detected  with  radio  receivers  or  photographic  plates. To  understand  geology, we must  look  at  geologic formations  and processes in many  parts  of the world where different  conditions have existed.  To understand  more about the  phenomena  of life, we must  study  the  behavior  of viruses,  single  cells,  plants,  and  animals  of  many  species.

A book was compiled covering various areas of research with Isaac Asimov writing an essay defending the value of basic research.

Thus, it was with some surprise and delight that we read in the news about Rep. Jim Cooper (D-Tenn) understanding the value of basic research.  The Washington Post reports that:

On Wednesday afternoon, Cooper rose to the defense of taxpayer-funded research into dog urine, guinea pig eardrums and, yes, the reproductive habits of the parasitic flies known as screwworms–all federally supported studies that have inspired major scientific breakthroughs.

Together with two colleagues he created the Annual Golden Goose Awards to honor federally funded research  “whose work may once have been viewed as unusual, odd, or obscure, but has produced important discoveries benefiting society in significant ways.”

Studying dog urine, among other stuff deem crazy by animal rights cranks, led to major medical discoveries

The article goes on to describe how research on dog urine led to an understanding of the effects of hormones on the human kidney, how studies in the guinea pig led to a treatment for hearing loss in infants, and how studies on the screwworm led to the effective control of the a deadly parasite that targets cattle.  All these provide additional examples refuting the notion that learning about life processes from animals cannot yield knowledge applicable to human health.

The Golden Goose Award has the backing of the American Association for the Advancement of ScienceAssociation of American Universities (who in 2011 published a series of “Scientific Inquirer” articles skewering dubious politically-motivated attacks on basic science) and the Progressive Policy Institute, who are to be congratulated for this excellent initiative to highlight the importance of basic research.

At the press conference to launch the award Rep. Robert Dold told reporters that “When we invest in science, we also invest in jobs. Research and development is a key part to any healthy economy,” while  Rep. Charlie Dent (R-Penn.) added “It’s critical, and the federal government has an important role to play,” who went on to describe how injecting horses with snake venom might “seem peculiar” but led to the discovery of the first anti-venom.

Taking us, once again, to the concluding words of Asimov’s essay:

Unless we continue with science and gather knowledge, whether or not it seems useful on the spot, we will be buried under our problems and find no way out.  Today’s science is tomorrow’s solution — and tomorrow’s problems , too — and, most of all, it is mankind’s greatest adventure, now and forever.

A welcome end to random-source dog and cat dealers

The National Institutes of Health has announced that starting October 1, 2012, NIH funds may no longer be used to buy cats from Class B dealers. A similar prohibition in the purchase of dogs from Class B dealers takes effect in 2015.

Although dogs and cats constitute only small percentage of research animals, they have been used in American biomedical research for over a century for studies of cardiovascular and neurological diseases, and for other areas of research including recent studies that led to a gene therapy for the eye disease Leber’s congenital amaurosis, whose success was reported widely last week.  The use of these animals is tightly regulated by the Animal Welfare Act, and they are only employed for studies where lower species do not provide adequate models.

Class B dealers are individuals licensed by the USDA under the Animal Welfare Act to resell animals they did not breed themselves. Class A dealers are breeders who do raise the animals themselves. Class B dealers may purchase dogs and cats from sources such as municipal pounds, from individuals who bred and raised the animals, and from other licensed dealers. They are required to keep records on where they got each animal and to hold pound animals for a minimum period so that if an unwanted animal was actually a stray, the owner has time to reclaim it.

Animal statistics in 2010 (US data) - Dogs account of 0.25% and cats 0.08% of the total number of animals used.

Class B dealers used to provide a large number of cats and dogs for research because they were virtually the only source for older animals and for some breeds. Regrettably, some Class B dealers used practices that violated the Animal Welfare Act both in terms of how they acquired animals and how they treated them.  The National Academies of Science studied the specific areas of science where Class B dogs and cats were being used and concluded that NIH could develop alternate supply mechanisms to replace them. NIH decided the best way to facilitate the transition was to provide an initial outlay of funds so that Class A dealers could begin raising older dogs of the breeds required for scientific research. It is expected that these breeders will be able to produce the necessary animals by 2015.

After October 1, 2012, NIH-grant supported research can only use cats from the following sources: Class A dealers, privately owned research colonies, or client owned animals, such as animals that participate in veterinary clinical trials.  The same policy will apply to dogs in 2015 when the Class A breeding program is in full swing.

The transition of NIH-funded research away from the use of Class B dogs and cats is an example of how measures can be taken to correct ethical problems regarding the treatment of animals.  When ethical concerns exist, thoughtful and deliberate steps can address those concerns, while preserving important biomedical research projects.

Bill Yates and Alice Ra’anan.

Bill Yates is the Chair of American Physiological Society Animal Care and Experimentation Committee. Alice Ra’anan is Director of Science Policy for the American Physiological Society. The views expressed above are exclusively those of Bill Yates and Alice Ra’anan and do not necessarily represent those of their employers.

A Proposal for the Labeling of Medicines

In a recent poll conducted by Zogby, 2,100 adults in the U.S. were asked the following question.

Do you agree or disagree with medical and scientific research that requires lab animals?

The results showed  a similar outcome to that of other recent polls.

About 52% of the population approve of animal research in various degrees, about 27% disapprove in various degrees, 15% are neutral and 6% are unsure about their position.

Despite the many polls done on the subject it remains unclear on what grounds do some people object to the use of animals in science.

Is it perhaps that they find the work morally wrong?  Is it that they believe all living beings have the basic rights to liberty and freedom?

Some insight into these questions can be gained by asking the same group of people what would the do in the following scenario.

Suppose you suffer from a leaky heart valve, and that doctors say you have two years left.   You could have a valve replacement surgery that might save your life.  But, in order to obtain the replacement tissue necessary for a surgery, a pig must be killed.

Which of the following statements best reflects what you would do if faces with a similar situation?

Statement A: I would have the surgery.  I think it is ethical.
Statement B: I would have the surgery, but I think it is unethical.
Statement C: I would not have the surgery, but I think it is ethical.
Statement D: I would not have the surgery because I think it is unethical.

Here are the results from the same poll:

Now, if one believes animals have rights they surely ought to be respected.  If you believe a pig has the same basic rights to life and freedom as your neighbor, then you ought to refuse the surgery for the same reason that you would not kill your neighbor to save your own life.

However, only a mere 3% of those asked appear ready to act in a way consistent with such a position.  It is interesting to note that also about 3% of the US population are vegetarian, although most of them do it for health reasons and not ethical objections to the use of animals as food.

Thus, those that oppose research do not appear to do so because of belief that all living beings have the same basic rights to life as that of fellow humans.

Another small minority, 2%, would not have the surgery despite the fact they think such surgical intervention is ethical.  It would appear this group simply is uncomfortable with the notion that pig tissue would be implanted in their human hearts.

About 12% of the group would opt to save their lives despite having ethical objections.  It appears this group feels there is something inherently wrong in killing an animal to allow them to survive and yet, if faced with the situation they would nonetheless go ahead with the surgery.  Arguably, this group realizes that the pig is a living being that we owe moral concern, but that when human and animal lives are at stake, opting to save the human is morally permissible.  Alternatively, they may genuinely opt for behaving in an immoral fashion when it comes to saving their own lives.

Finally, the vast majority, 73% of them, will opt for the surgery without having any moral concerns whatsoever.   None at all.   That is roughly 3 out of 4 people in the US population.

A natural question is then why wouldn’t the same group, at the very least, be in favor of animal research that advances medical knowledge and human health?

One likely possibility is that they fail to see the direct link between research and the therapies and medicines that it produces.  They fail to see that the medicine that will save their lives next time they visit the emergency room will be, in all likelihood, the result of animal research.  They may wrongly perceive basic and translational research as two being completely different things.  The contribution of basic knowledge to human health may be lost in translation.

So, what can be done?

Aside from scientists and physicians reaching out to educate the public on this matters, we could begin by labeling each and every single medication that resulted from basic research in animals with such basic information.  Note that I am not talking about safety testing in animals — which is required by the law.  Instead, I am referring to medicines developed through the identification of molecular targets or the discovery of specific mechanisms with the use of animals in basic research.  In other words, I propose to label medicine as derived from animal research if it actually produced the knowledge that actually allowed scientists to understand how a particular therapy could be developed.

Shouldn’t the public be entitled to know where their medicines come from? Shouldn’t the public be entitled to understand the range of benefits produced by their tax dollars?

What do you think?

Ignorance or Deception?

Animal rights activists may want to start cooling down their engines.

Apparently, by 2050 we can expect the complete elimination of animal use in science.

At least, this is the prediction made by Dr. Andrew Rowan, Chief Scientific Officer of the Humane Society of the United States (HSUS) in a recent article that appeared in The Scientist.

The title of the piece was “Avoiding Animal Testing.  Advances in cell-culture technologies are paving the way to the complete elimination of animals from laboratories”.

The first half of the article focuses on the development and adoption of alternatives to the use of animals in toxicology.  Our public health officials and the FDA have long made the sensible decision to require any company that introduces new chemicals or drugs into the market to provide an initial experimental assessment of their potential toxicity to humans.

This use of animals for such safety screening is typically called animal testing.

Dr. Rowan correctly points out that advances in the development toxicology methods may allow us eventually to relax the regulations that require the use of animals in testing.  But he rapidly moves to insinuate such advances imply that by 2050 we could see the end of animal use in laboratories:

This overall decline in animal use can be attributed to the advent of novel technologies such as improved cell-culture systems and micro-analytic techniques; more sophisticated model systems; improved understanding of signaling and metabolic pathways; and a host of other new methods that allow scientists to answer important questions about the functioning of healthy and diseased tissues without subjecting whole animals to harmful procedures. With a 50 percent decline in animal research since 1975, we are roughly at the halfway point towards the complete elimination of animal research. Thus, we argue that, by 2050, we might finally see the last of animal use in the laboratory, particularly if all stakeholders put their minds to it.

First, the assertion that the total use of animals is systematically declining is not supported by the data.  The slide below, for example, was taken from a recent talk Dr. Rowan gave at the University of Wisconsin.  It shows the total number of animals used has been stable since the mid 80s, with the number of non-genetically modified (Non-GM, faint dashed line) animals decreasing and stabilizing in the 90s (see also data here), while the number of  genetically modified (GM) animals, which are largely mice, has been systematically increasing.

Second, even if correctly asserting that we can expect a diminished need for animals in toxicology testing, Dr. Rowan’s generalization of such trend from a such narrow field to all of biomedical research is groundless and misleading.

Let us be clear, our universities do not engage in animal testing, but in animal research.

What’s the difference?

Scientists are largely concerned with elucidating the basic mechanisms of biological processes in health and disease.  We want to study how cells in our bodies work, how they communicate, how they develop, how they age and how they die.   We want to understand how the brain, our immune system, and internal organs work and how they fail.  And so on…

Why is it critical we develop such an understanding?

Because without this knowledge there will be no hope to combat disease. Indeed, the mission of the National Institutes of Health (NIH) recognizes this fundamental fact in its opening statement,

NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life and reduce the burdens of illness and disability.

Implicit in such declaration is the acknowledgment that it is basic knowledge that drives advancements in human health and well-being.  Basic knowledge of nature is what drives progress.  This point is critical –   translational or applied research would not exist without basic knowledge as the raw material.  Without knowledge there would be nothing to translate nor apply.

Those that declare an imminent end to the use of animals in science are effectively implying that they envisage all basic knowledge needed will be acquired by a certain date, or that we will have methods that would allow us to proceed with studies non-invasively in human volunteers. Dr. Rowan’s statement that “Advances in cell-culture technologies are paving the way to the complete elimination of animals from laboratories” is nothing short of utter scientific nonsense.

Is it possible for Dr. Rowan to be ignorant of the role of animals in scientific research?  Could he legitimately be confused about the difference between safety testing on one hand and the development of therapies and basic research on the other?

This seems highly unlikely giving his academic credentials and the fact that he has served on IACUCs before.  In fact, another slide from his talk, shows him delineating these different uses of animals, and illustrating that animal testing for human safety accounts for merely ~25% of total animal use.

No, Dr. Rowan is not confused at all.  He knows what he is talking about.  This is unfortunate as one can only conclude his article is simply a misguided attempt to deceive the public about the fields in which we might realistically expect science to successfully replace animals in the near future.

And I emphasized science above for a good reason.

As difficult as it is for animal advocates to understand, scientists also believe we will see a day when we can eliminate the use of animals in all animal research.  And the day will arrive because of the hard work, progress and achievements of dedicated scientists, such as this one, and not because of deception of those that want to oppose animal research at all cost.

For HSUS to suggest that all animal research could be eliminated by 2050 is  flatly wrong from a scientific point of view, and utterly irresponsible from a public health perspective.

What Cost Savings? A Closer Look at the Great Ape Protection and Cost Savings Act of 2011

The status and future of chimpanzee research in the US are at the heart of much discussion lately in both scientific and public (also here and here) spheres.  A committee convened by the Institute of Medicine (IOM) to consider the issue held a number of meetings and is expected to report its findings to the NIH by the end of this year. Legislation to end great ape research, also introduced in 2007 and 2009 (H.R. 1513: Great Ape Protection and Cost Savings Act of 2011;  S. 810: Great Ape  Protection and Cost Savings Act of 2011; GAPA), was again introduced last Spring. This is the fourth of a series of posts aimed at encouraging thoughtful and fact-based consideration of the full range of complex issues associated with chimpanzee research and both short- and long-term responsibility for their welfare, care and housing. Posts include:

08/12/11: Facts must inform discussion of future of chimpanzee research.

10/13/11: Joseph M. Erwin, PhD Efforts to ban chimpanzee research are misguided.

11/21/11: A closer look at the Great Ape Protection Act.

Previous posts and other discussions of chimpanzee research have focused on ethical questions, animal welfare, and ongoing evaluation of the role chimpanzees do play, or should play, in scientific research.  These are the most important issues to address in discussion of the future of great apes in the U.S. At the same time, this year’s version of the Great Ape Protection Act has included a new focus, with addition of the phrase “and Cost Savings.”  The new language and the calculations given as basis for its assertions have received relatively little careful broad discussion or evaluation.

According to cost analysis for the legislation compiled by the Humane Society of the United States, the majority of cost-savings from GAPA – 76% – would result from ending federal grants for projects involving chimpanzees.  Of the “nearly $30 million saved annually” over $22 million reflects funds committed to support research projects that involve chimpanzees and are funded by the National Institutes of Health (NIH).

HSUS GAPA Cost Analysis

It appears that this number was arrived at by summing the cost of all NIH grants that involve chimpanzees, regardless of their topic or the types of activities in which the animals are engaged. Whether this number could reflect the total funds invested in what is commonly considered invasive research is not readily apparent. Some of these grants may involve noninvasive studies, others may be dedicated to studies that require as little as samples of DNA—something commonly done in human studies. It does appear that the underlying assumption for the cost analysis is a complete block on any NIH research grants that involve chimpanzees. (We welcome correction if this is not an assumption of the HSUS analysis or any cost analysis used to support the claims associated with GAPA.)

The remaining savings are projected from reduction in care costs if the animals were moved to sanctuaries.  Whether sanctuaries provide lower-cost care than research facilities is subject to some debate, in part because care costs vary across facilities. This is illustrated in the most recent data published by the National Center for Research Resources (NCRR) October 31, 2011 “Costs for Maintaining Humane Care and Welfare of Chimpanzees:”

Based on the most recent awards and payments, NIH is spending an average of $35 per day per chimpanzee in research facilities; $67.00 per day per chimpanzee in the research reserve facility at Alamogordo Primate Facility (APF); and $47 per day per chimpanzee in the federal sanctuary facility operated by Chimp Haven. The average for research facilities becomes $44 per day if the research reserve facility at APF is included. See Table 1 for detailed figures.”

The reasons for variance in costs are complex. Among other things, they do not reflect differences in housing, clinical care, or health status of the animals (e.g., older animals or animals with chronic health problems may require more expensive treatment and care). But overall, the numbers reported by NCRR show a rough equivalence in care costs at the federal sanctuary and many research facilities.

Table 1 “Costs for Maintaining Humane Care and Welfare of Chimpanzees, October 31, 2011

Research

Facility

# of Chimpanzees,
as of 10/31/11
(total)

NCRR cost*,
$M/year
(total)

NCRR cost,
$/animal/day,
(avg)

NIRC

117

1.23

28.8

K-CCMR

154

2.56

45.5

SNPRC (P51)

125

1.02

22.4

SNPRC (U42)

25

.047

56.3

Total

(421)

(5.3)

(34.5)

Research Reserve

Facility

# of Chimpanzees,
as of 10/31/11
(total)

NCRR cost*,
$M/year
(total)

NCRR cost,
$/animal/day,
(avg)

APF

173

4.25

67.4

Federal Sanctuary

Facility

# of Chimpanzees,
as of 10/31/11
(total)

NCRR cost*,
$M/year
(total)

NCRR cost,
$/animal/day,
(avg)

Chimp
Haven

119

2.03

46.7

What is not shown by these numbers or by most of the discussion of GAPA are the number of other issues that should accompany thoughtful consideration of the long-term care and housing of chimpanzees.  Dr. Joseph Erwin provided commentary on many of these in a previous guest post, among them concerns about ensuring the highest quality of care for the animals:

Most chimpanzees in scientific and educational institutions (research colonies and zoological gardens) live in spacious, social, and secure environments, where they are provided with excellent professional healthcare, and are afforded protection under the Animal Welfare Act, through inspection by the USDA, and publicly available reports of those inspections. The legislative ban would require removal of chimpanzees from decent facilities that were built at great public expense, and would deposit hundreds of chimpanzees in “sanctuaries” that provide no assurance of competent professional care, are not subject to Animal Welfare Act protection, and are not publicly transparent.”

One of the biggest unanswered (and virtually unmentioned in public spheres) questions surrounding the effects of this legislation is where it is that these chimpanzees would go? Is the intent that they would stay in current facilities? That new facilities would be constructed? While some animal rights groups have advocated for moving chimpanzees from their current research facilities to Chimp Haven, there is little information that would indicate that is a feasible option. Nor do the discussions of cost-savings and future plans include information about projected costs to build sufficient sanctuary space that could accommodate the number of animals currently housed in research facilities.

This is a non-trivial issue. For example, the publicly-available NCRR cost information informs us that the cost to construct the only federally-funded chimpanzee sanctuary, Chimp Haven, was $11.8 million. Chimp Haven houses 130 animals.  In other words, the initial construction cost was just over $90,000 per chimpanzee.

There are an additional 594 NIH-supported chimpanzees currently housed in research facilities. There are also hundreds of privately-owned chimpanzees. Thus, on even rough calculation based on the construction cost of Chimp Haven, it would appear that at least many millions of dollars would be required to extend the capacity for sanctuary housing to these animals. 

 

The cost, feasibility, and plan for constructing additional facilities that could provide care for these chimpanzees does not seem apparent in the cost calculations for the current legislation. Nor is it an issue raised much in public discussion.  It is a relatively easy thing to call for an end to chimpanzee research and to encourage public support by appealing to fiscal conservatism. What is far more challenging is to include consideration of real factors that significantly influence the outcomes for the animals, including an accurate assessment of where they can be housed, how best practices for care can be supported, real costs and dedicated sources of funding for long-term maintenance and facilities. Those details matter and deserve far more attention than they currently receive by those claiming to have chimpanzees’ welfare as the utmost priority.

Allyson J. Bennett